fundvisualizer.com

T. Rowe Price International Eq IndexPIEQX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2024
Stock
0.70%
Non-U.S. Stock
99.04%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.02%
Other
0.24%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2024

Basic materials

6.66%

Consumer cyclical

9.66%

Financial services

19.48%

Real estate

2.23%

Consumer defensive

8.27%

Health care

13.13%

Utilities

3.11%

Communication services

4.67%

Energy

3.54%

Industrials

16.50%

Technology

9.41%

Top 10 holdings

As of 09/30/2024

Msci Eafe Fut 12/24
2.24%
Novo Nordisk AS Class B
2.11%
ASML Holding NV
1.85%
Cash Offsets For Shorts & Derivatives
1.63%
Trp Government Reserve
1.57%
Nestle SA
1.47%
AstraZeneca PLC
1.34%
SAP SE
1.32%
Novartis AG Registered Shares
1.26%
Roche Holding AG
1.25%
Fund assets

$816.69 Million

Share class

Inv

Morningstar category

Foreign Large Blend

Expense ratio

0.26%

Investment objective

Growth

Documents